225 related articles for article (PubMed ID: 11985057)
1. [Standardization of the laboratory method for antithrombin activity measurement].
Okajima K
Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
[TBL] [Abstract][Full Text] [Related]
2. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
3. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of antithrombin and heparin cofactor II deficiency.
Tollefsen DM
Semin Thromb Hemost; 1990 Apr; 16(2):162-8. PubMed ID: 2191430
[TBL] [Abstract][Full Text] [Related]
5. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
Tran TH; Zbinden B; Lämmle B; Duckert F
Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
7. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
[TBL] [Abstract][Full Text] [Related]
8. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
[TBL] [Abstract][Full Text] [Related]
9. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Dupouy D; Sié P; Dol F; Boneu B
Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
[TBL] [Abstract][Full Text] [Related]
10. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
[TBL] [Abstract][Full Text] [Related]
11. [Activities of antithrombin III and heparin cofactor II in patients with pathologic blood coagulation conditions].
Hirokawa S; Kaji T; Tazawa K; Fujimaki M; Hayashi T; Niiya K; Sakuragawa N
Rinsho Ketsueki; 1992 Mar; 33(3):281-7. PubMed ID: 1578630
[TBL] [Abstract][Full Text] [Related]
12. [The second cofactor of heparin].
Sie P
Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
[TBL] [Abstract][Full Text] [Related]
13. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
14. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
[TBL] [Abstract][Full Text] [Related]
15. Turnover study of heparin cofactor II in healthy man.
Sié P; Dupouy D; Pichon J; Boneu B
Thromb Haemost; 1985 Oct; 54(3):635-8. PubMed ID: 3841420
[TBL] [Abstract][Full Text] [Related]
16. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
17. [Determination of serum antithrombin for the detection of plasmatic hypercoagulability in acute cardiac-circulatory diseases. I. Enzymatic method for the determination of serum anti-thrombins].
Duck HJ; Köhler H; Fiedler G
Z Gesamte Inn Med; 1978 Apr; 33(8):242-7. PubMed ID: 208314
[No Abstract] [Full Text] [Related]
18. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
19. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
20. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
Andersson TR
Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
